American Century Companies’s Matinas BioPharma MTNB Stock Holding History
Bought
Maintained
Sold
Other funds holding MTNB
RJFSA
AWMG
IA
BCM
American Century Companies's MTNB Position: Q1 2018 in Review
American Century Companies sold out of Matinas BioPharma (MTNB) in Q1 2018, closing a stake of 2,664 shares — an estimated $155K sold.
American Century Companies first reported a position in MTNB in Q4 2017 and held it in 1 quarter. The position peaked at $155K in Q4 2017. 45 funds tracked by Wall St. Rank hold MTNB as of Q1 2018.
- American Century Companies reported no remaining Matinas BioPharma position as of Q1 2018 after selling out during the quarter.
- American Century Companies sold 2,664 Matinas BioPharma shares in Q1 2018, an estimated $155K.
- American Century Companies first reported a position in Matinas BioPharma in Q4 2017 and held it in 1 quarter.
- American Century Companies's Matinas BioPharma position peaked at $155K in Q4 2017.
- 45 funds tracked by Wall St. Rank held Matinas BioPharma as of Q1 2018.
Based on American Century Companies's 13F filing for Q1 2018, filed 3 May 2018.